Drug Intelligence
EU AI Act: Implications for Pharma R&D Workflows
The EU's new AI regulations introduce significant compliance requirements for pharma companies using AI-driven drug discovery and clinical trial tools.
Knowledge Base
Stay ahead of global compliance trends with expert analysis, regulatory updates, and product development intelligence.
Drug Intelligence
The EU's new AI regulations introduce significant compliance requirements for pharma companies using AI-driven drug discovery and clinical trial tools.
Regulatory Affairs
New guidance from FDA's Digital Health Center clarifies pathways for AI/ML-based software as a medical device submissions.
Market Access
NICE has published updated guidance on economic modeling for high-cost therapies, with new thresholds for gene and cell therapy submissions.